239 related articles for article (PubMed ID: 28802503)
1. Fibrohistiocytic Tumors.
Romano RC; Fritchie KJ
Clin Lab Med; 2017 Sep; 37(3):603-631. PubMed ID: 28802503
[TBL] [Abstract][Full Text] [Related]
2. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
[TBL] [Abstract][Full Text] [Related]
3. [Fibrohistiocytic skin tumors].
Hügel H
J Dtsch Dermatol Ges; 2006 Jul; 4(7):544-55. PubMed ID: 16827912
[TBL] [Abstract][Full Text] [Related]
4. [Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].
Mentzel T
Pathologe; 2015 Feb; 36(1):79-88. PubMed ID: 25589356
[TBL] [Abstract][Full Text] [Related]
5. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
Franchi A; Santucci M
Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
[TBL] [Abstract][Full Text] [Related]
6. Nonepithelial skin tumors with multinucleated giant cells.
Gómez-Mateo Mdel C; Monteagudo C
Semin Diagn Pathol; 2013 Feb; 30(1):58-72. PubMed ID: 23327730
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous soft tissue tumors: how do we make sense of fibrous and "fibrohistiocytic" tumors with confusing names and similar appearances?
Hornick JL
Mod Pathol; 2020 Jan; 33(Suppl 1):56-65. PubMed ID: 31653978
[TBL] [Abstract][Full Text] [Related]
8. [Fibrohistiocytic tumor of skin].
Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):134-7. PubMed ID: 23710926
[No Abstract] [Full Text] [Related]
9. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
Lazova R; Moynes R; May D; Scott G
Cancer; 1997 Jun; 79(11):2115-24. PubMed ID: 9179057
[TBL] [Abstract][Full Text] [Related]
10. S100A6 expression in fibrohistiocytic lesions.
Fullen DR; Reed JA; Finnerty B; McNutt NS
J Cutan Pathol; 2001 May; 28(5):229-34. PubMed ID: 11401666
[TBL] [Abstract][Full Text] [Related]
11. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
12. [The ultrastructure of fibrous and histiocytic skin tumors (dermatofibroma, dermatofibrosarcoma protuberans, fibroxanthoma, and histiocytoma) (author's transl)].
Auböck L
Virchows Arch A Pathol Anat Histol; 1975 Oct; 368(3):253-74. PubMed ID: 171831
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous and subcutaneous fibrohistiocytic tumors of intermediate malignancy: an update.
Billings SD; Folpe AL
Am J Dermatopathol; 2004 Apr; 26(2):141-55. PubMed ID: 15024197
[TBL] [Abstract][Full Text] [Related]
14. Cellular fibrous histiocytoma of the skin: evidence of a clonal process with different karyotype from dermatofibrosarcoma.
Vanni R; Marras S; Faa G; Licheri S; Daniele GM; Fletcher CD
Genes Chromosomes Cancer; 1997 Apr; 18(4):314-7. PubMed ID: 9087573
[TBL] [Abstract][Full Text] [Related]
15. Low proliferative activity in common dermatofibroma does not necessarily guarantee a low proliferation in all dermatofibroma variants.
Fernandez-Flores A
Arch Pathol Lab Med; 2008 Feb; 132(2):160; author reply 160-1. PubMed ID: 18251566
[No Abstract] [Full Text] [Related]
16. CD34-positive myxoid dermatofibrohistiocytoma of the skin: an indolent post-traumatic tumor that can be mistaken for dermatofibrosarcoma protuberans.
Al-Quran SZ; Russo JJ; Bandarchi-Chamkhaleh B; Hassanein AM
J Cutan Pathol; 2009 Jan; 36(1):84-6. PubMed ID: 19125740
[No Abstract] [Full Text] [Related]
17. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
Cohen PR; Rapin RP; Farhood AI
Am J Dermatopathol; 1994 Oct; 16(5):573-4. PubMed ID: 7528477
[No Abstract] [Full Text] [Related]
18. Immunohistochemical observation of intracytoplasmic lysozyme in proliferative and neoplastic fibrohistiocytic lesions.
Nakanishi S; Shinomiya S; Sano T; Hizawa K
Acta Pathol Jpn; 1982 Nov; 32(6):949-59. PubMed ID: 6297236
[TBL] [Abstract][Full Text] [Related]
19. Giant xanthomatous dermatofibroma--a case distinguished histologically and immunohistochemically from invasive fibrohistiocytic tumors.
Sato N; Aiba S; Maie O; Tomita Y
Dermatology; 1995; 190(1):67-71. PubMed ID: 7894102
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
